# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 561-565 of 565 results.
Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)
Status: Recruiting
Last Changed: Mar 27, 2019
First Received: Jan 30, 2014
Disease(s): Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL
Intervention(s): CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T Cells - dose escalation 1
Locations: Houston Methodist Hospital, Houston, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Subjects With B-cell Malignancies
Status: Recruiting
Last Changed: Sep 11, 2019
First Received: Jun 10, 2016
Disease(s): Lymphoma, Leukemia
Intervention(s): BGB-3111, BGB-A317
Locations: St Vincent's Hospital, Darlinghurst, New South Wales, Australia
St Vincent's Hospital, Kogarah, New South Wales, Australia
Concord Hospital, Sydney, New South Wales, Australia
Royal Hobart Hospital, Hobart, Tasmania, Australia
Monash Hospital, Clayton, Victoria, Australia
... and 7 other locations.
CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
Status: Recruiting
Last Changed: Dec 03, 2018
First Received: Sep 02, 2015
Disease(s): Leukemia, Lymphoma
Intervention(s): CD19-directed CAR-T cells
Locations: Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China
MB-CART19.1 in Patients With R/R ALL
Status: Not yet recruiting
Last Changed: Oct 25, 2017
First Received: Oct 25, 2017
Disease(s): Precursor B-Lymphoblastic Lymphoma/Leukaemia Refractory
Intervention(s): MB-CART19.1
A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase
Status: Recruiting
Last Changed: Jul 31, 2019
First Received: Feb 24, 2015
Disease(s): Lymphoma, Acute Lymphoblastic Leukemia
Intervention(s): Apixaban, No systemic anticoagulant prophylaxis
Locations: Phoenix Children'S Hospital/Ctr. For Cancer & Blood Ctr., Phoenix, Arizona, United States
City of Hope, Duarte, California, United States
Loma Linda University Cancer Center, Loma Linda, California, United States
Childrens Hospital Of La, Los Angeles, California, United States
Local Institution, Los Angeles, California, United States
... and 101 other locations.